1999
DOI: 10.1016/s0003-4975(99)00523-8
|View full text |Cite
|
Sign up to set email alerts
|

Progress with the HeartSaver ventricular assist device

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2000
2000
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 11 publications
0
5
0
1
Order By: Relevance
“…To the best of our knowledge, previous efforts to combine RM with ventricular assist devices (VADs) have not yielded products available in the market yet , except the HeartAssist‐5 LVAD (MicroMed Cardiovascular, Inc., Houston, TX, USA). The HeartAssist‐5 LVAD, formerly known as the MicroMed DeBakey VAD , is currently the unique LVAD that has RM technology.…”
Section: Methodsmentioning
confidence: 99%
“…To the best of our knowledge, previous efforts to combine RM with ventricular assist devices (VADs) have not yielded products available in the market yet , except the HeartAssist‐5 LVAD (MicroMed Cardiovascular, Inc., Houston, TX, USA). The HeartAssist‐5 LVAD, formerly known as the MicroMed DeBakey VAD , is currently the unique LVAD that has RM technology.…”
Section: Methodsmentioning
confidence: 99%
“…It is a very good choice for energy harvesting for bio-medical devices [20]. For humans, a space of several cubic centimeters is available, for example, up to 480 cm 3 [21]. First of all, the diaphragm is a strong muscle.…”
Section: The Diaphragm Muscle As An Energy Sourcementioning
confidence: 99%
“…The second feature of this muscle is that it provides us a relatively large space for placing electrostatic generator. For humans, a space of several cubic centimeters is available, for example, up to 480 cm 3 [21]. Another feature of the diaphragm muscle is its continuous movement.…”
Section: The Diaphragm Muscle As An Energy Sourcementioning
confidence: 99%
“…A series of in vivo bovine studies with durations of support up to 30 days has been performed. Preparations for future human use are awaiting regulatory approval 64 (Figure 18). …”
Section: Future Prospectsmentioning
confidence: 99%